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1. Introduction
Fructose is a monosaccharide abundant in many fruits, vegetables, 
honey, high fructose corn syrup, soft drinks and prepackaged foods. It 
was initially considered a beneficial sweetener for diabetic patients due 
to its low glycemic index compared to glucose; however, recently, it has 
been shown that overconsumption of fructose can be pathogenic. Stud-
ies have provided strong evidence of its adverse effects on human and 
animal health [1]. Fructose is predominantly and rapidly metabolized 
in the liver where it promotes de novo lipogenesis [1]. Fructose con-
sumption has been shown to enhance the risk of metabolic syndrome, 
including obesity and insulin resistance and type 2 diabetes (T2D) by 
accelerating de novo lipogenesis and increasing very low-density lipo-
protein (VLDL) biogenesis in humans and animal models [1,2]. Fructose 
overconsumption has been reported to cause adverse metabolic ef-
fects such as increased visceral and intrahepatic fat accumulation, which 
are known to promote the development of nonalcoholic fatty liver dis-
ease (NAFLD), a highly prevalent liver disease that is linked with meta-
bolic disorders such as obesity, T2D, hypertension and cardiometabolic 
disease [1]. Although ample research, including epidemiological stud-
ies, has described the harmful effects of fructose on human and animal 
health, the underlying molecular processes behind its lipogenic effects 
are still poorly understood.
MicroRNAs (miRNAs) are small noncoding RNA (~22 nucleotide 
long) that regulate gene expression and function. They bind to the 3′-
UTR or 5′-UTR of target mRNA and either suppress protein transla-
tion or promote mRNA degradation [3]. More importantly, it has been 
shown that a single miRNA has the potential to target multiple mRNAs, 
and a single mRNA can be targeted by multiple miRNAs, which in turn 
enables them to regulate several groups of mRNAs within a signal-
ing pathway or network and generate a powerful impact on diverse 
cellular processes [4]. Thus, understanding how dietary factors such 
as fructose and fat can alter miRNA expression and characterizing the 
diet-induced changes in expression of miRNA and their target mRNA 
is key to understanding the molecular mechanisms underlying the 
metabolic syndrome.
miRNAs induced by high-fat diet (HFD) have drawn considerable 
attention because of their critical roles in the pathogenesis of meta-
bolic disorders [5]. However, the impact of high-fructose diet on he-
patic miRNA expression profiles and the putative role of these miRNAs 
in fructose-induced hyperlipidemia and insulin resistance are not fully 
understood. In this study, we identified a new set of hepatic miRNA 
whose expression profiles were significantly altered by high fructose 
diet using small RNA deep sequencing, followed by in-depth bioin-
formatics analysis. Subsequent target prediction and pathway func-
tional enrichment analysis further identified that the targeted mRNAs 
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Abstract
Fructose is a highly lipogenic sugar that can alter energy metabolism and trigger metabolic disorders. In the current study, microR-
NAs (miRNAs) altered by a high-fructose diet were comprehensively explored to elucidate their significance in the pathogenesis of 
chronic metabolic disorders. miRNA expression profiling using small noncoding RNA sequencing revealed that 19 miRNAs were sig-
nificantly upregulated and 26 were downregulated in the livers of high-fructose-fed mice compared to chow-fed mice. Computa-
tional prediction and functional analysis identified 10 miRNAs, miR-19b-3p, miR-101a-3p, miR-30a-5p, miR-223-3p, miR-378a-3p, 
miR-33-5p, miR-145a-3p, miR-128-3p, miR-125b-5p and miR-582-3p, assembled as a regulatory network to potentially target key 
genes in lipid and lipoprotein metabolism and insulin signaling at multiple levels. qRT-PCR analysis of their potential target genes 
[IRS-1, FOXO1, SREBP-1c/2, ChREBP, insulin-induced gene-2 (Insig-2), microsomal triglyceride transfer protein (MTTP) and apoli-
poprotein B (apoB)] demonstrated that fructose-induced alterations of miRNAs were also reflected in mRNA expression profiles of 
their target genes. Moreover, the miRNA profile induced by high-fructose diet differed from that induced by high-fat diet, indicat-
ing that miRNAs mediate distinct pathogenic mechanisms in dietary-induced metabolic disorders. This study presents a compre-
hensive analysis of a new set of hepatic miRNAs, which were altered by high-fructose diet and provides novel insights into the in-
teraction between miRNAs and their target genes in the development of metabolic syndrome.
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of these miRNAs assembled as hubs which regulate multiple key met-
abolic pathways associated with the onset of diet-induced metabolic 
disorders. We further compared the miRNA profiles induced by HFD 
with those induced by high-fructose diet and discovered that their 
miRNA expression profiles were different with certain miRNAs that 
were upregulated by fructose but downregulated by HFD or vice versa. 
This may suggest that fructose and HFD induced metabolic disor-
ders via different pathogenic pathways. In summary, our study pro-
vides novel mechanistic insights into the fructose-induced hyperlip-
idemia and insulin resistance by identifying a novel miRNA network 
and their interaction with the key genes in lipid and carbohydrate 
metabolic signaling.
2. Materials and methods
2.1. Animal protocols
All animal experiments were approved by the University of Nebraska–Lin-
coln Institutional Animal Care and Use Committee and were carried out un-
der the institutional guidelines for ethical animal use. Male mice (C57BL/6J) 
at 12 weeks of age were purchased from Jackson Laboratory (Bar Harbor, 
ME, USA). MiR-378a-depleted mice (miR-378-KO) and their wild-type (WT) 
littermates are a kind gift from Dr. Vincent Giguere (McGill University, Mon-
treal, Canada). Animals were housed on alternating 12-h light and dark cy-
cles with free access to food and water. After a week of acclimatization, two 
groups of mice (n=6/per group) were fed either chow (Envigo, Madison, 
WI, USA; ID: 2016) or a high-fructose diet (60% fructose, ID: 161.506; Dy-
ets, Bethlehem, PA, USA) for 4 weeks. Dietary compositions are provided 
in Table 1. Food intake and body weight were monitored every 3 days. In-
traperitoneal (ip) glucose tolerance tests were performed weekly. Briefly, 
mice were fasted for 12 h and then received glucose (2 g/kg, ip) and blood 
glucose was measured via tail vein bleeding using a handheld glucometer 
(Contour/Next; Bayer). At the end of the feeding trial, mice were fasted for 
12 h and anesthetized using isoflurane and livers were excised, frozen in 
liquid nitrogen and stored at −80 °C for further analysis.
2.2. Cell culture, transfection and treatments
The rat hepatoma cell line McA-RH7777 (McA) was obtained from Amer-
ica Type Culture Collection (ATCC, Manassas, VA, USA) and maintained in 
Dulbecco’s modified Eagle medium (DMEM) containing 10% fetal bovine 
serum (FBS), 4.5 g/L glucose and 0.5% penicillin/streptomycin. Cells were 
grown in T75 flasks at 37 °C, 5% CO2, with the media changed every other 
day and cells passaged every 3–4 days. For transfection, the cells were 
seeded onto 6-well plates (0.3×106) and maintained in DMEM-contain-
ing 4.5 g/L glucose. When the cells reached 60%–70% confluence, cells 
were transfected with 1.0 μg of plasmid cDNA encompassed either a GFP 
reading frame or miR-125b-5p (Vigene Biosciences, Rockville, MD, USA) 
by Lipofectamine 2000. Twenty-four hours after transfection, the cells were 
treated with palmitate (PA; 100 μM) in DMEM (4.5 g/L) without FBS for ad-
ditional 24 h. Total RNAs were collected at the end points of each treat-
ment as described below.
2.3. miRNA extraction and miRNA sequencing profiling
Total RNA, including miRNA, was isolated from the chow- and fructose-
fed mouse livers using miRNeasy Mini Kit (Qiagen) following the manu-
facturer’s instructions. The miRNA profiling was conducted using Illimina 
HiSeq 2500 sequencer by Genomics and Microarray Core in UT Southwest-
ern Medical Center (Dallas, TX, USA). Libraries were prepared using Illu-
mina TruSeq Small RNA Sample preparation kit (Illumina, USA). Six repli-
cates were sequenced for each treatment.
2.4. RNA isolation, reverse transcription and qRT-PCR
Total RNA was isolated from tissue using TRIzol (Life Technologies, Grand 
Island, NY, USA). RNA integrity was confirmed using a NanoDrop 2000 
(Wilmington, DE, USA). First-strand cDNA was synthesized with oligo (dT) 
and random primers using a High-Capacity cDNA Reverse Transcription Kit 
with RNase Inhibitor (Life Technologies). Quantification of gene expression 
was performed on Applied Biosystems real-time-PCR system StepOneP-
lus. Relative induction of gene mRNA expression was calculated using the 
expression of 18s for normalization. Sequences of forward and reverse 
primers (5′ to 3′) used in this study are shown in Supplementary Table 1.
2.5. MiRNA sequencing data analysis
For bioinformatics analysis, the CAP-miSeq was applied to identify mouse 
miRNAs and calculate their expression [6]. The miRBase (Version 21) was 
used as reference library ( http://www.mirbase.org ). We have carefully fil-
tered out the low-quality reads and strictly mapped the qualified reads to 
all known mature sequences, precursor sequences and the mouse genome. 
The differentially expressed miRNAs between fructose- and chow-fed mice 
were analyzed using the R package, edgeR and only those miRNAs with P 
value<.05 were considered significantly differential [7]. Hierarchical cluster-
ing ( http://bonsai.hgc.jp/~mdehoon/software/cluster/software.htm ) was 
performed and a heat map was generated to show the differential gene pat-
terns where green represented downregulation while red represented up-
regulation compared to the chow-fed controls.
2.6. Target prediction and functional analysis
As the functions of miRNA can be inferred based on its gene target, we ex-
tracted the known miRNA gene targets from miRTarBase [8], DIANA-Tar-
base and also predicted new targets using MiRanda ( http://www.microrna.
org ) and TargetScan ( http://www.targetscan.org ). The gene interaction 
network was generated through Cytoscape [9].
2.7. Statistical analyses
Statistical analysis of qRT-PCR data was done with GraphPad Prism 6 (La 
Jolla, CA, USA) using Student’s t test. All results are presented as means 
± S.E.M. Asterisks (*) indicate statistically significant differences of P<.05 
compared to controls.
3. Results
3.1. High-fructose feeding induces insulin resistance which is 
accompanied with aberrant expression of miRNAs in mouse livers
To establish an insulin-resistant animal model, two groups of C57BL/6J 
mice (n=6/group) were fed either chow or a high-fructose diet (60% 
caloric from fructose). Caloric intake was monitored daily and was 
found to be comparable between chow- and fructose-fed mice (Sup-
plementary Figure 1A). Body weights were comparable between chow- 
and fructose-fed mice during the first 2 weeks of feeding, but were 
significantly increased in the fructose-fed mice from week 3 (Supple-
mentary Figure 1B). At week 4 of high-fructose feeding, plasma tri-
glycerides and cholesterol were significantly higher in the fructose-fed 
mice compared to the chow-fed mice (Supplementary Figure 1C), indi-
cating the development of hyperlipidemia. Glucose tolerance tests fur-
ther showed that plasma glucose levels in the fructose-fed mice were 
significantly higher at 30, 60, 90 and 120 min compared to the chow-
fed mice after glucose injection (Supplementary Figure 1D), suggesting 
the development of glucose intolerance in these mice. To investigate 
the impact of high-fructose feeding on hepatic miRNA expression, 
miRNAs were extracted from livers and subjected to miRNA expres-
sion profiling by illumine-based deep sequencing. 303 mature miR-
NAs were detected through small noncoding RNA sequencing anal-
ysis. Among them, expression profiles of 45 miRNAs were found to 
be significantly different (P <.05) between fructose feeding and chow 
diet. Of these 45 miRNAs, 19 were upregulated and 26 were down-
regulated with fructose feeding. A heat map was constructed to vi-
sualize the changes of these miRNAs (Figure 1A). Relative expression 
of these miRNAs in the livers of chow- and fructose-fed mice is pre-
sented in Figure 1B. These results indicate that aberrant expression of 
miRNA profiles may be associated with the development of hyperlip-
idemia and insulin resistance in the fructose-fed mice.
Table 1. Detailed composition of the diets in this study
Ingredients (% mass)  Chow  Fructose
Protein  16.4  22.21
Fat  4  6.0
Starch and fibers  52.0  Trace
Fructose  Trace  60.0
Neutral detergent fiber  15.2  7.09
Calories from protein (%)  22  21.77
Calories from fat (%)  12  14.77
Calories from carbohydrate (%)  66  62.37
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3.2. Fructose-induced miRNAs are extensively involved in lipid and 
carbohydrate metabolic pathways
Bioinformatics analysis showed that 10 out of the 45 miRNAs were as-
sembled as a regulatory network that collaboratively targets multiple 
metabolic signaling molecules involved in lipid and lipoprotein metab-
olism [e.g., SREBP-1c/2, ChREBP, insulin induced, gene-2 (Insig-2), and 
apolipoprotein B (apoB)] and insulin signaling (e.g., IRS-1 and FOXO1) 
(Figure 2; Tables 2A and 2B). The following miRNAs were downregu-
lated: miR-223-3p, miR-33-5p, miR-145a-3p, miR-125b-5p and miR-
128-3p, and the following miRNAs were upregulated: miR-19b-3p, 
miR-101a-3p-3p, miR-30a-5p, miR-378a-3p and miR-582-3p (Tables 
2A and 2B). Computing prediction further revealed that the potential 
target genes of these miRNAs included IRS-1 and FOXO-1 that medi-
ate insulin signaling, SREBP-1c, SREBP-2, ChREBP, and Insig-2 (insig-
2a and -2b) that are associated with hepatic de novo lipid synthesis as 
well as MTTP and apoB that are involved in VLDL assembly and secre-
tion [10–13]. A schematic elucidating the network of interactions be-
tween these miRNAs, their potential target genes and the pathways 
involved is presented in Figure 2 (solid lines represent connections 
between miRNAs and potential target genes and broken lines rep-
resent associations between miRNAs and metabolic pathways). This 
network indicated that one miRNA can be involved in multiple path-
ways, whereas one gene can be a common target of several miRNAs 
that were induced by fructose feeding. For example, miR-223-3p po-
tentially regulates mRNA expression of IRS-1 and apoB, and may be 
involved in pathways associated with insulin resistance and NAFLD 
(Table 2A). However, at the same time, IRS-1 is also a common target 
of miR-33-5p, miR-128-3p, miR-145a-3p, miR101a-3p, miR-125b-5p 
and miR-30-5p (Tables 2A and 2B). Detailed association between the 
aberrantly expressed miRNAs induced by high-fructose feeding, their 
potential target genes and the pathways are described in Tables 2A 
and 2B. This intriguing finding further stresses the unique and com-
plex regulatory nature of miRNAs on cellular activity. It is now well ac-
cepted that an individual miRNA has the ability to regulate several 
groups of genes within a signaling pathway, whereas multiple miR-
NAs can assemble as a network to collectively target a key gene in a 
signaling pathway [4]. This action significantly amplifies the regulatory 
effects of miRNAs in diverse cellular and physiological activities [4].
3.3. The association between fructose-induced miRNAs and their 
putative target genes
To determine whether expression of the potential target genes was 
altered with fructose feeding, we measured the mRNA levels of IRS-1, 
FOXO1, SREBP-1c/2, ChREBP (Mlxipl), Insig-1, Insig-2, MTTP and apoB 
in the livers of chow- and fructose-fed mice by qRT-PCR. Expression of 
IRS-1 and Insig-2 (Insig-2a and Insig-2b) mRNAs was significantly re-
duced, whereas mRNAs of FOXO1, SREBP-1c, SREBP-2, ChREBP, MTTP 
and apoB were significantly increased in the fructose-fed mice com-
pared to chow-fed mice (Figure 3A–D). The expression profiles of these 
mRNAs inversely correlated with the abundances of their predicted 
miRNAs, suggesting that aberrant expressions of these miRNAs may, 
at least partially, contribute to the abnormal mRNA expression of these 
Figure 1. Heat map depicting miRNA expression profile of chow- and fructose-fed mouse livers (P value <.05 from the exact test in edgeR). (A) Each 
column represents either chow- or fructose-fed mice and each row represents one miRNA. Green color indicates downregulation and red color in-
dicates upregulation with respect to chow diet. The color scale illustrates miRNA expression levels with increased expression ranging from green to 
red. (B) Bar graph depicting fold change (log2) in miRNA expression in fructose-fed compared to chow-fed liver. n=6/group.
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genes (Figures 1A and 3A–D). For instance, downregulation of miR-
223-3p, miR-33-5p, miR-145a-3p, miR-125b-5p and miR-128-3p by 
fructose feeding may account for the increased mRNA abundance of 
FOXO1, ChREBP, MTTP and apoB due to the decreased interaction be-
tween these miRNAs and their target mRNAs (Figure 3A–D; Table 2A). 
On the other hand, upregulation of miR-101a-3p, miR-30a-5p and 
miR-378a-3p seems to target mRNAs of IRS-1 and Insig-2 which re-
sulted in decreased mRNA expression of these two genes (Figure 3A–
D; Table 2B).
Expression of the miR-378 family, including miR-378a, b, c and 
d, and miR-125a/b, was either significantly upregulated or downreg-
ulated upon fructose feeding (Figure 1A and B). To specifically de-
termine the relationship between miRNAs and their potential target 
genes, we manipulated the expression of miR-378a and miR-125b-5p 
via genetic intervention or in vitro overexpression. We overexpressed 
a plasmid vector encompassed miR-125b-5p in McA cell and deter-
mined mRNA expression of MTTP and apoB by qRT-PCR. As shown in 
Figure 3E, mRNA abundance of MTTP was significantly reduced in the 
miR-125b-5p overexpressing cells compared to mock transfected cells 
(Figure 3E). Presence of miR-125b-5p further prevented free fatty acid, 
palmitic acid (PA), induced overexpression of apoB mRNA (Figure 3F). 
Next, we subjected the WT and genetic depletion of miR-378a mice 
(miR-378a-KO) to the high-fructose diet and found that depletion of 
miR-378a protected the mice from fructose-induced reduction of PI3K 
and IRS-1 (Figure 3G). Interestingly, we found that the abundance of 
miR-19b-3p and miR-582-3p was not inversely associated with their 
target mRNAs. Upregulation of these two miRNAs was found to be 
associated with increased mRNA levels of their target genes, such as 
Figure 2. MiRNA–mRNA network: schematic showing relationship between putative miRNA target genes analyzed by qRT-PCR with the correspond-
ing miRNA targeting them and the metabolic pathways associated with energy metabolic processes such as hepatic de novo lipogenesis, lipid and 
lipoprotein metabolism, insulin signaling and NAFLD. Solid lines represent connections between miRNAs and potential target genes. Red solid lines 
are for upregulated miRNAs and green solid lines for downregulated miRNAs. Broken lines represent associations between and metabolic pathways. 
Purple broken lines: insulin signaling and insulin resistance; brown broken lines: lipoprotein biosynthesis; black broken: fatty acid and triglyceride 
biosynthesis and NAFLD; and gray broken: cholesterol biosynthesis.
Table 2A. Fructose-downregulated miRNAs, their key target genes and the associated pathways
MiRNAs  Target mRNA  Pathways
miR-223-3p  IRS-1, ApoB  Insulin signaling, insulin resistance, fatty acid, triglyceride and lipoprotein biosynthesis and NAFLD
miR-33-5p  IRS-1, ChREBP, ApoB  Insulin signaling, insulin resistance, fatty acid, triglyceride and lipoprotein biosynthesis and NAFLD
miR-128-3p  IRS-1, FOXO1, MTTP  Insulin signaling, insulin resistance, fatty acid, triglyceride and lipoprotein biosynthesis and NAFLD
miR-125b-5p  IRS-1, SREBP-1c, SREBP-2,   Insulin signaling, insulin resistance, fatty acid, triglyceride, lipoprotein and cholesterol biosynthesis and   
         Insig-2, ChREBP, ApoB    NAFLD
miR-145a-3p  IRS-1, FOXO1, MTTP, ChREBP, ApoB  Insulin signaling, insulin resistance, fatty acid, triglyceride and lipoprotein biosynthesis and NAFLD
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FOXO1, SREBP-1c/2, ChREBP, and apoB (Figure 3A–D; Table 2B). At a 
glance, this is at odds with the widely accepted view of miRNA func-
tion to downregulate their target genes. However, recent studies have 
found that in addition to targeting mRNA degradation, miRNAs can 
also upregulate mRNA expression. The mRNA expression could be ac-
tivated by the direct action of micro-ribonucleoproteins (miRNPs) and/
or indirectly relieved from miRNA-mediated repression by abrogating 
the action of repressive miRNPs [14]. Taken together, our study iden-
tifies a set of metabolic genes which are common targets of the miR-
NAs induced by fructose feeding. Our data further implies that an in-
dividual miRNA has the potential to either downregulate or upregulate 
its targeted mRNAs simultaneously, whereas an individual mRNA can 
be targeted by multiple miRNAs. This finding is in agreement with the 
recently identified mechanisms of action of miRNAs.
3.4. Identification of novel physiological function for the fructose in-
duced miRNAs
In an attempt to identify additional novel functions of the 10 miRNAs 
that are altered by fructose feeding, we conducted intensive litera-
ture research for the reported physiological activities of these miR-
NAs. We found that miR-33-5p, also known as miR-33, is a well-char-
acterized miRNA that is profoundly involved in hepatic triglyceride and 
cholesterol metabolism through targeting SREBP-1c gene expression 
[19]. In the current study, we found that expression of miR-33 was in-
versely associated with the mRNA abundance of ChREBP (Figures 1A 
and 3B), a major transcription factor involved in de novo lipogenesis in 
response to high-carbohydrate diet [1]. This may suggest that miR-33 
could also regulate ChREBP in fructose metabolism. The reduced miR-
33 in the fructose-fed mice may be responsible, at least partially, for 
the activation of ChREBP and the subsequent hyperlipidemia induced 
by high-fructose feeding. Identification of ChREBP as a potential tar-
get of miR-33 broadens the targeting profile of miR-33 and may pro-
vide rationale for using this miRNA to treat carbohydrate-induced hy-
perlipidemia. Moreover, we found that miR-101a-3p, miR-30a-5p and 
miR-582-3p have been reported to be involved in various cellular ac-
tivities other than energy metabolic signaling. For example, expression 
of miR-101 is associated with skeletal muscle cell proliferation and dif-
ferentiation [15] and can protect cardiac fibroblasts against hypoxia-
induced apoptosis [16]. Cellular abundances of miR-30a-5p and miR-
582-3p are implicated in the development of breast cancer [17] and 
bladder cancer [18]. Thus, the current study would be the first to re-
port that these three miRNAs are also involved in regulating lipid and 
carbohydrate metabolism. Our study further identified that miR-145a-
3p, whose biological relevance has not been defined yet, may play a 
role in fructose-induced metabolic disorders because its expression 
Table 2B. Fructose-upregulated miRNAs, their key target genes and the associated pathways
MiRNAs  Target mRNA  Pathways
miR-101a-3p  IRS-1, SREBP-2, Insig-2, MTTP, ApoB  Insulin signaling, insulin resistance, fatty acid and triglyceride, lipoprotein, cholesterol biosynthesis and NAFLD
miR-30a-5p  IRS-1, Insig-2, MTTP, ApoB  Insulin signaling, insulin resistance, fatty acid and TG, lipoprotein biosynthesis and NAFLD
miR-378a-3p  SREBP-1c, ChREBP, ApoB  Insulin signaling, insulin resistance, fatty acid and TG, lipoprotein biosynthesis and NAFLD
miR-19b-3p  FOXO1, SREBP-1c, SREBP-2, ChREBP  Insulin signaling, insulin resistance, fatty acid and TG, lipoprotein, cholesterol biosynthesis and NAFLD
miR-582-3p  FOXO1, ApoB  Insulin signaling, insulin resistance and lipoprotein biosynthesis.
Figure 3. Relative expression of potential target mRNAs of aberrant expressed miRNA using qRT-PCR. RNA samples from livers of chow- and fruc-
tose-fed mice (n=6/group) were reverse transcribed and mRNA levels of the putative target genes were determined by qRT-PCR. (A) FOXO1, IRS-1; 
(B) SREBP-1c, SREBP-2 and ChREBP; (C) Insig-1, Insig-2a and Insig-2b; and (D) MTTP and apoB. (E & F) mRNA levels of MTTP (MTP) (E) and apoB 
(F) in McA cells overexpressing miR-125b-5p or a mock vector untreated or treated with palmitic acid (PA) (100 μM) for 24 h. (G) mRNA levels of PI3K 
and IRS-1 in the wild-type (WT) or miR-378a-KO (KO) mice fed with fructose diet. Data were normalized to 18srRNA. Results are shown as mean± 
S.E.M., n=6/group. *P <.05 vs. controls.
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profile was significantly downregulated by fructose (Figure 1A and B). 
Taken together, our study revealed that in addition to their roles in 
cancer development and cell proliferation, miR-101a-3p, miR-30a-5p, 
miR-582-3p and miRNA-145a-3p are involved in lipid and carbohy-
drate metabolism and may contribute to the onset of metabolic syn-
drome induced by high-fructose feeding.
3.5. High-fructose diet and HFD induce different miRNA expression 
profiles in the livers
To explore whether the fructose-induced miRNA profile differs from 
that by HFD, we searched for published miRNA data sets that may 
have similar experimental design as ours but used high-fat feeding 
instead of high fructose. Conducting vigorous literature research in 
the GEO database (http://www.ncbi.nlm.nih.gov/geo/ ) and PubMed, 
we found very little literature on this topic. We then used the miR-
NAs listed in Figure 1A as a starting point and searched for the ex-
pression patterns of each individual miRNA under high-fat feed-
ing condition for comparison. Due to the limited reports on high 
fat-induced miRNA profiles, we were unable to collect a complete 
profile match from HFD. Expression patterns of the miRNAs with 
high-fructose feeding diet (from current study) and HFD (from lit-
erature reports) are presented in Table 3. Interestingly, we no-
ticed that the expression patterns of miRNAs induced by fructose 
differed from those induced by HFD (Table 3). MiR-99b-5p, miR-
150-5p, miR-100-5p, miR-223-3p and miR-128-3p that were down-
regulated by fructose were upregulated in the livers of high fat-fed 
rats or mice (Table 3) [5,20]. In contrast, miR-130a, miR-30a-5p, miR-
203-3p, miR-574-5p and miR-20a-5p that were induced by high-
fructose feeding were reduced in the high fat-fed rats or mice (Table 
3) [5,21,22]. This intriguing finding suggests that different molecu-
lar mechanisms are involved in the development of metabolic syn-
drome induced by these two lipogenic diets.
4. Discussion
4.1. Fructose-induced miRNAs in hepatic insulin signaling
In this study, we found that IRS-1 was inhibited by fructose feeding 
which could be a consequence of the increased expression of miR-30a-
5p, miR-101a-3p, miR-378a-3p and/or the decreased expression of 
miR-145-3p, miR-33, miR-223-3p, miR-125b-5p and miR-128-3p as 
all of these miRNA content seed sequences to potentially interact with 
the 3′-UTR of IRS-1 mRNAs. IRS-1 mediates insulin signaling by re-
laying the signal from the insulin receptor to downstream signaling 
molecules that regulate glucose and lipid metabolism [13]. Regulation 
of IRS1 by miR-128a has been reported previously to be involved in 
myoblast proliferation and myotube hypertrophy in skeletal muscle 
[26]. Determination of miR-128-3p, along with other miRNAs stated 
above, in regulating expression of IRS-1mRNAin the livers of fructose-
fed mice provides novel mechanistic insight into the fructose-induced 
metabolic disorders. The observation that IRS-1 could be a common 
target of multiple miRNAs further strengthens the concept that mul-
tiple miRNAs can assemble as a regulatory network to repeatedly tar-
get an individual mRNA and generate synergistic impact on the ex-
pression of the target gene [4].
In this study, we observed that the mRNA abundance of FOXO1 
was elevated in the livers of fructose-fed mice. FOXO1 belongs to the 
family of forkhead transcription factors involved in several cellular pro-
cesses, including cell division, DNA repair, apoptosis, insulin signal-
ing and lipid metabolism [27]. This observation is in accordance with 
a previous study which showed that protein levels of FOXO1 were in-
creased by high-fructose feeding in hamsters [28]. Bioinformatics pre-
diction further revealed that FOXO1 could be a potential common tar-
get of miR-19b-3p, miR-145-3p, miR-128-3p and miR-582-3p. It is very 
likely that the decreased levels of miR-145 and/or miR-128 caused by 
fructose feeding ease their inhibitory effects on FOXO1 mRNA expres-
sion, thus increasing FOXO1 expression and contributing to the on-
set of diet-induced hyperglycemia. Regulation of FOXO1 by miRNAs 
highlights the complexity and fine balance between diverse cellular 
signaling in maintaining metabolic homeostasis.
4.2. Fructose-induced miRNAs in hepatic lipid and lipoprotein 
metabolism
The development of hyperlipidemia is closely associated with the de-
velopment of T2D [1]. Hepatic de novo lipid synthesis is controlled by 
SREBPs, which induce expression of genes involved in fatty acid, tri-
glyceride and cholesterol synthesis [11]. Activation of SREBPs is regu-
lated by three ER membrane-bound proteins — Insig-1, Insig-2, and 
SCAP protein [29]. Low cellular sterol triggers the dissociation of the 
SCAP-SREBP complex from Insig-1 and Insig-2, thus allowing SCAP-
SREBP complex to move to the Golgi apparatus, where the SREBPs are 
activated by proteolytic cleavage [29]. Hyperlipidemia is one of the 
major pathological phenotypes observed in high fructose-induced in-
sulin-resistant rodent models. However, the underlying mechanisms 
are not fully understood. Our study suggests that reduced expression 
of Insig-2 may derepress the inhibitory effect of Insig-2 on the pre-
cursors of SREBPs and enhance activation of SREBP-1c and -2, which 
may result in hyperactivation of SREBPs, leading to the activation of 
hepatic de novo lipogenesis. The increased lipid substrates along with 
elevated levels of apoB and MTTP might favor the assembly and se-
cretion of VLDL from hepatocytes and contribute to the hyperlipid-
emia induced by fructose.
In summary, our study identified a novel set of miRNAs that are ab-
normally expressed in the livers of fructose-fed mice. These miRNAs 
assemble as a regulatory network that cooperatively targets lipid met-
abolic pathways and insulin signaling at multiple levels to amplify its 
regulatory effect on the target genes and contribute to pathogenesis 
of fructose-induced insulin resistance. The miRNA profile induced by 
high-fructose feeding differs from that of HFD, which implicates the 
different metabolic mechanisms in high fructose- and high fat-induced 
metabolic disorders. This study provides novel insight into the molec-
ular mechanism of pathogenesis of high-fructose diet-induced meta-
bolic syndrome and may provide rationale for pharmaceutical design 
to manipulate the expression of miRNAs in the prevention and treat-
ment of high carbohydrate-induced metabolic syndrome.
Table 3. Hepatic miRNA expression profiles altered by high fructose 
(HFru) diet and HFD
MiRNAs  HFru   HFD   Species  Ref. 
 (current study) (reported studies)
miR-99b-5p  Down  Up  Rat liver  [5]
miR-150-5p Down  Up  Rat Liver  [5]
miR-100-5p  Down  Up  Rat Liver  [5]
miR-223-3p  Down  Up  Rat liver  [5]
miR-128-3p  Down  Up  Mouse liver  [20]
miR-33-5p  Down  Down  Mouse liver  [23]
miR-130a  Up  Down  Rat Liver  [5]
miR-30a-5p  Up  Down  Rat Liver  [5]
miR-203-3p  Up  Down  Rat Liver  [5]
miR-574-5p  Up  Down  Hepatocyte cell line  [21]
miR-20a-5p  Up  Down  Mouse liver  [22]
miR-34a-5p  Up  Up  Mouse liver  [24]
miR-378a-3p  Up  Up  Mouse liver  [25]
miR-125b-5p  Down  –  – –
miR-145a-3p  Down  –  – –
miR-101a-3p  Up  –  – –
miR-19b-3p  Up  –  – –
miR-582-3p  Up  –  – –
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Supplemental Table 1- Primers used in this study  
FOXO1 
Forward ATGTGTTGCCCAACCAAAGC 
 Reverse AGGACTTTTAAATGTAGCCTGCTC 
IRS-1 
Forward ACATCACAGCAGAATGAAGACC 
Reverse GAAGAGGAAGACGTGAGGTCC 
MTTP 
Forward CCGGTCAAGCGTTGCATTTC 
Reverse AGAGCATTTCGTCTGTTTCGC 
Insig-1 
Forward ACACGTGGGACCTAACTTGC 
Reverse TCTGAAATGACCCGAGAACC 
Insig-2a 
Forward CCCTCAATGAATGTACTGAAGGATT 
Reverse TGTGAAGTGAAGCAGACCAATGT 
Insig-2b 
Forward CCGGGCAGAGCTCAGGAT 
Reverse GAAGCAGACCAATGTTTCAATGG 
ApoB 
Forward CGTGGGCTCCAGCATTCTA 
Reverse TCACCAGTCATTTCTGCCTTTG 
18S 
 
Forward TAAGTCCCTGCCCTTTGTACACA 
Reverse 
GATCCGAGGGCCTCACTAAAC 
 
ChREBP 
Forward CTGGGGTCTGATGCCAGAAG 
Reverse CACACCAACACCAACCCTTG 
SREBP-2 
Forward GTGGAGCAGTCTCAACGTCA 
Reverse TGGTAGGTCTCACCCAGGAG 
 
 
